Skip to content
Clinical Trial Events
SCDM 2025 Annual Conference

Panel Risk-Based CDM track

From Noise to Insight: Leveraging Pareto’s Principle to Streamline RB-CDM

Sun, Sep 28, 2025 · 11:30 AM–12:30 PM EDT Ballroom I-II, Baltimore Convention Center

About this session

Session chaired by Christina Dinger
Description:
In clinical trials, not all risks are created equal — yet too often, study teams treat them as if they are. The result? Bloated risk registers, wasted resources, and diminished focus on the risks that truly threaten trial success.
This engaging session brings together industry experts to explore how Pareto’s Principle (the 80/20 rule) can transform risk-based clinical data management (RB CDM). Together, they’ll discuss first-hand experiences and provide actionable strategies to — cut through the noise, spotlight the vital 20% of risks, and design targeted mitigation approaches that protect data quality, safeguard participants, and save valuable time.
Attendees will gain valuable perspectives on:
- Tried & true methodologies that remain the foundation of effective RB CDM, including CTQ linkage, the prioritization of contemporaneous risks, and rule-based decision matrices to streamline risk mitigation.
- Forward-looking capabilities available today, including how technology and AI are enhancing risk prioritization and monitoring.
- Bold predictions about how automation and evolving regulations may further reshape RB CDM in the years to come and how to be ready.
If you’re ready to move beyond exhaustive, scattershot risk management and instead focus where it counts, join us to discover how to turn noise into insight — and insight into action.

Speakers

  • Pavel Burmenko

    Strategy Lead, Veeva CDB · Veeva

    Speaker

  • Christina Dinger

    Assoc. VP of Product & Marketing · ThoughtSphere

    Speaker

  • Yun Lu

    VP & Chief Science and Innovation Officer · Navitas Clinical Research, Inc.

    Speaker

  • Cilla Mistry

    Associate Director · GSK

    Speaker

  • Shobhit Shrotriya

    Managing Director, Life Sciences R&D Operations · Accenture

    Speaker